Korea Research Institute of Bioscience and Biotechnology (KRIBB)
- Korea Institute of Science and Technology (KIST)
- National Institute of Green Technology (NIGT)
- Korea Basic Science Institute (KBSI)
- Korea Astronomy and Space Science Institute (KASI)
- Korea Research Institute of Bioscience and Biotechnology (KRIBB)
- Korea Institute of Science and Technology Information (KISTI)
- Korea Institute of Oriental Medicine (KIOM)
- Korea Institute of Industrial Technology (KITECH)
- Electronics and Telecommunications Research Institute (ETRI)
- National Security Research Institute (NSRI)
- Korea Institute of Civil Engineering and Building Technology (KICT)
- Korea Railroad Research Institute (KRRI)
- Korea Research Institute of Standards and Science (KRISS)
- Korea Food Research Institute (KFRI)
- World Institute of Kimchi (WIKIM)
- Korea Institute of Geoscience and Mineral Resources (KIGAM)
- Korea Institute of Machinery and Materials (KIMM)
- Korea Aerospace Research Institute (KARI)
- Korea Institute of Energy Research (KIER)
- Korea Electrotechnology Research Institute (KERI)
- Korea Research Institute of Chemical Technology (KRICT)
- Korea Institute of Toxicology (KITOX)
- Korea Atomic Energy Research Institute (KAERI)
- Korea Institute of Materials Science (KIMS)
- Korea Institute of Fusion Energy(KFE)

Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Construction and operation of R&D and public infrastructure in the fields of life science and technology
President | Kim, Jang seong |
---|---|
Establishment Date | 1985.02.01 |
Location | KRIBB, 125, Gwahak-ro, Yuseong-gu, Daejeon |
Contact | 042-860-4114 |
Homepage | www.kribb.re.kr |
Key Functions
- To drive the development and supply of source technology in the advanced bio-science technology and the bio-economy
- Bio-convergence innovation, future growth engine creation, and bio agenda resolution
- TO providepublic infrastructure supprot for the research on domestic and foreign bio-science
- Public infrastructure support, national policy think-tank, training of specialized professionals, commercialization support for SMEs
Recent Achievements
- Elucidation of the mechanism for controlling inflammation caused by active oxygen
- Completion of the second clinical trial targeted at NK cells refractory cancer patients
- Discovery of new micro RNA of NK cells
- Investigation of the reaction mechanism of the cells to the active oxygen
- Phase II of chronic obstructive pulmonary disease (COPD) treatment drug clinical trial for the FDA approval
- Development of pathogenic and antibiotic resistance gene analysis system
- Development of technology to search larvae hormone counter substances that regulate the transformation and molting of insects